Passive and active immunoprophylaxis of hepatitis B.
D000328:Adult; D000917:Antibody Formation; D002353:Carrier State / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D004306:Dose-Response Relationship, Immunologic; D005260:Female; D006506:Hepatitis A / Q000517:prevention & control; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control*; D006510:Hepatitis B Antibodies / Q000008:administration & dosage*; D017325:Hepatitis B Vaccines; D006801:Humans; D007116:Immunization, Passive / Q000379:methods*; D007117:Immunization, Secondary; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control; D013997:Time Factors; D014611:Vaccination / Q000379:methods*; D014765:Viral Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology
D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines; D014765:Viral Vaccines